Sitra Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.30 Cr
as on 18-07-2024
- Paid Up Capital ₹ 1.30 Cr
as on 18-07-2024
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 3.58 Cr
as on 18-07-2024
- Satisfied Charges ₹ 2.00 Cr
as on 18-07-2024
- Revenue 53.76%
(FY 2022)
- Profit 58.67%
(FY 2022)
- Ebitda 68.69%
(FY 2022)
- Net Worth 65.84%
(FY 2022)
- Total Assets 18.12%
(FY 2022)
About Sitra Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.30 Cr and a paid-up capital of Rs 1.30 Cr.
The company currently has active open charges totaling ₹3.58 Cr. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Virendra Sehra and Upendra Sehra serve as directors at the Company.
- CIN/LLPIN
U74999DL2010PTC208789
- Company No.
208789
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Sep 2010
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sitra Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Upendra Sehra  | Director | 18-Jan-2017 | Current |
| Virendra Sehra | Director | 11-Aug-2021 | Current |
Financial Performance and Corporate Structure Insights of Sitra Biotech.
Sitra Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 53.76% increase. The company also saw a substantial improvement in profitability, with a 58.67% increase in profit. The company's net worth Soared by an impressive increase of 65.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sitra Biotech?
In 2022, Sitra Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Concept Media And Computech Private LimitedActive 24 years 6 months
Virendra Sehra is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 Jan 2023 | ₹3.58 Cr | Open |
Others Creation Date: 07 Sep 2022 | ₹1.00 Cr | Satisfied |
Bank Of India Creation Date: 07 Dec 2013 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Sitra Biotech?
Sitra Biotech has a workforce of 2 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sitra Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sitra Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
